US Bancorp’s Mustang Bio MBIO Stock Holding History

US Bancorp’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20	Closed	-$1.35K	–	4047
2023 Q4	$1.35K	Hold	20	–	–	﹤0.01%	3767
2023 Q3	$2.07K	Hold	20	–	–	﹤0.01%	3650
2023 Q2	$6.21K	Hold	20	–	–	﹤0.01%	3420
2023 Q1	$5.5K	Buy	+20	New	+$8.2K	﹤0.01%	3492

Other funds holding MBIO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

US Bancorp's MBIO Position: Q1 2024 in Review

US Bancorp sold out of Mustang Bio (MBIO) in Q1 2024, closing a stake of 20 shares — an estimated $1.35K sold.

US Bancorp first reported a position in MBIO in Q1 2023 and held it in 4 quarters. The position peaked at $6.21K in Q2 2023. 27 funds tracked by Wall St. Rank hold MBIO as of Q1 2024.

US Bancorp reported no remaining Mustang Bio position as of Q1 2024 after selling out during the quarter.
US Bancorp sold 20 Mustang Bio shares in Q1 2024, an estimated $1.35K.
US Bancorp first reported a position in Mustang Bio in Q1 2023 and held it in 4 quarters.
US Bancorp's Mustang Bio position peaked at $6.21K in Q2 2023.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.